Literature DB >> 18566666

Homocysteine and cardiovascular disease: should we treat?

Kathleen Potter1.   

Abstract

Entities:  

Year:  2008        PMID： 18566666      PMCID： PMC2423315     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN： 0159-8090


× No keyword cloud information.
  39 in total

1.  Lowering homocysteine for stroke prevention.

Authors:  Cynthia M Carlsson
Journal:  Lancet       Date:  2007-06-02       Impact factor: 79.321

2.  B vitamins for the prevention of vascular disease: insufficient evidence to justify treatment.

Authors:  Colin Baigent; Robert Clarke
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

Review 3.  Folate and carcinogenesis: an integrated scheme.

Authors:  S W Choi; J B Mason
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

Review 4.  Will mandatory folic acid fortification prevent or promote cancer?

Authors:  Young-In Kim
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

5.  Radioenzymic determination of homocysteine in plasma and urine.

Authors:  H Refsum; S Helland; P M Ueland
Journal:  Clin Chem       Date:  1985-04       Impact factor: 8.327

6.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

7.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

8.  Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.

Authors:  P Galan; A de Bree; L Mennen; G Potier de Courcy; P Preziozi; S Bertrais; K Castetbon; S Hercberg
Journal:  J Nutr Health Aging       Date:  2003       Impact factor: 4.075

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

10.  Homocysteine and stroke: evidence on a causal link from mendelian randomisation.

Authors:  Juan P Casas; Leonelo E Bautista; Liam Smeeth; Pankaj Sharma; Aroon D Hingorani
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321
View more
  1 in total

Review 1.  Homocysteine lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.